Inhibition of Myostatin Reduces Collagen Deposition in a Mouse Model of Oculopharyngeal Muscular Dystrophy (OPMD) With Established Disease
BackgroundOculopharyngeal muscular dystrophy (OPMD) is a late-onset muscle disease presented by ptosis, dysphagia, and limb weakness. Affected muscles display increased fibrosis and atrophy, with characteristic inclusion bodies in the nucleus. Myostatin is a negative regulator of muscle mass, and in...
Main Authors: | Pradeep Harish, Leysa Forrest, Shanti Herath, George Dickson, Alberto Malerba, Linda Popplewell |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-03-01
|
Series: | Frontiers in Physiology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fphys.2020.00184/full |
Similar Items
-
Inhibition of myostatin improves muscle atrophy in oculopharyngeal muscular dystrophy (OPMD)
by: Pradeep Harish, et al.
Published: (2019-10-01) -
Oculopharyngeal muscular dystrophy - an under-diagnosed disorder?
by: M Plasilov, et al.
Published: (2005-10-01) -
PABPN1 overexpression leads to upregulation of genes encoding nuclear proteins that are sequestered in oculopharyngeal muscular dystrophy nuclear inclusions
by: Louis-Philippe Corbeil-Girard, et al.
Published: (2005-04-01) -
Novel Metabolomic Approach for Identifying Pathology-Specific Biomarkers in Rare Diseases: A Case Study in Oculopharyngeal Muscular Dystrophy (OPMD)
by: Pradeep Harish, et al.
Published: (2023-06-01) -
A Japanese case of oculopharyngeal muscular dystrophy (OPMD) with PABPN1 c.35G > C; p.Gly12Ala point mutation
by: Yo-suke Nishii, et al.
Published: (2021-07-01)